France Blood Collection Devices Market (2025-2030)
The France Blood Collection Devices Market was valued at $426.3 Million in 2025 and projected to reach to $595.9 Million by 2030, representing a compound annual growth rate of 6.9%. France's blood collection devices market is poised for steady growth through 2030, supported by an aging population requiring frequent diagnostic testing and a healthcare system prioritizing worker safety.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
France Blood Collection Devices Market Trends and Insights
- France's healthcare infrastructure and aging population are driving demand for advanced phlebotomy solutions and safety-engineered devices.
- The French market benefits from strong regulatory frameworks and increasing adoption of automated blood collection systems across hospitals and diagnostic laboratories. In France, the blood collection devices sector is experiencing steady growth driven by rising diagnostic testing volumes and heightened focus on occupational safety standards.
- France's emphasis on reducing needlestick injuries and improving specimen quality has accelerated the uptake of innovative collection technologies.
- Between 2025 and 2030, France is expected to see sustained investment in healthcare modernization, supporting market expansion and the introduction of next-generation collection devices tailored to French clinical workflows..
Key Market Statistics
- CAGR (2025-2030) 6.9% CAGR
- Market Size, 2025 ~USD 426.3 Million
- Forecast, 2030 ~USD 595.9 Million
- Country France
France Blood Collection Devices Market Overview
Market Valuation :
France's blood collection devices market is valued at USD 426.3 million in 2025 and is projected to reach USD 595.9 million by 2030, representing a steady CAGR of 6.9%.
Aging Population Driver :
France's demographic shift toward an aging population is significantly increasing demand for routine blood testing and phlebotomy procedures, driving adoption of advanced collection devices.
Safety-Engineered Devices :
French healthcare providers are increasingly adopting safety-engineered and needle-stick prevention devices, driven by strict occupational safety regulations and healthcare worker protection mandates.
Regulatory Excellence :
France's robust regulatory framework and compliance with EU medical device directives ensure high-quality standards, fostering innovation and market growth in blood collection technologies.
France Blood Collection Devices Market Dynamics
- The French market benefits from strong regulatory oversight and healthcare infrastructure investments, which encourage adoption of advanced phlebotomy solutions.
- Hospitals, diagnostic laboratories, and blood banks across France are increasingly investing in safety-engineered devices to reduce occupational hazards and improve patient outcomes.
- The market's 6.9% CAGR reflects consistent demand from both public and private healthcare sectors, with particular emphasis on innovation in needle-stick prevention technologies and automated collection systems..
Related Ecosystem
In Vitro Diagnostics
- Polymerase Chain Reaction (PCR)
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Dna Microarrays
- Assay Kits
- Microarrays
- ROCHE HOLDINGS AG
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Abbott Laboratories
- Biomerieux s.a.
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- CONMED Corporation
Key Takeaways
- France's blood collection devices market is valued at USD 426.3 million in 2025 and will reach USD 595.9 million by 2030, growing at 6.9% CAGR.
- France's aging population and increased diagnostic testing demand are primary growth drivers for blood collection device adoption.
- Safety-engineered and automated collection systems are gaining traction in France due to stringent occupational health regulations.
- France's robust healthcare infrastructure and investment in diagnostic modernization support sustained market expansion through 2030.
Blood Collection Devices Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | PLASMA/WHOLE BLOOD TUBES (Type) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 7.4% from 2025 to 2030 |
| Largest Segment | MANUAL BLOOD COLLECTION (Method) |
| Market Size Base Year (Billions) | ~USD 9.11 (2025) |
| Revenue Forecast (Billions) | ~USD 13.02 (2030) |
| Segments Covered | Product, Type, System Type, Method, Application, End User |
France Blood Collection Devices Market Report Segmentation
6 segment dimensions are covered across the global market.
By Product
- Blood Bags
- Blood Collection Systems/ Monitors
- Blood Collection Tubes
- Lancets
- Needle & Syringes
By Type
- Coagulation Tubes
- Edta Tubes
- Esr Tubes
- Glucose Tubes
- Heparin Tubes
- Plasma/Whole Blood Tubes
- Serum Tubes
By System Type
- Non-Vacuum Type
- Vacuum Type
By Method
- Automated Blood Collection
- Manual Blood Collection
By Application
- Diagnostic Applications
- Therapeutic Applications
By End User
- Blood Banks
- Diagnostic & Pathology Labs
- Hospitals, Ambulatory Surgical Centers, And Nursing Homes
- Other End Users
FRANCE: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2023–2030
| Segment | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| BLOOD BANKS | 63.9 | 67 | 69.7 | 72.7 | 76.4 | 80.5 | 85.1 | 90.3 | 5.3 |
| DIAGNOSTIC & PATHOLOGY LABS | 86.1 | 91.6 | 96.6 | 102.3 | 108.9 | 116.4 | 124.8 | 134.4 | 6.8 |
| HOSPITALS, AMBULATORY SURGICAL CENTERS, AND NURSING HOMES | 205.7 | 220.7 | 234.7 | 250.4 | 268.7 | 289.4 | 312.7 | 339.2 | 7.6 |
| OTHER END USERS | 23.4 | 24.5 | 25.3 | 26.3 | 27.4 | 28.8 | 30.3 | 32 | 4.8 |
| TOTAL | 379.1 | 403.8 | 426.3 | 451.7 | 481.4 | 515 | 552.9 | 595.9 | 6.9 |
Target Audience
- Medical Device Manufacturers : Manufacturers need France-specific market data to develop localized product strategies, understand regulatory requirements, and identify distribution opportunities in the French healthcare system.
- Healthcare Facility Administrators : Hospital and laboratory administrators require market insights to benchmark procurement decisions, evaluate supplier options, and justify investments in safety-engineered blood collection devices.
- Diagnostic Laboratory Operators : Laboratory managers need detailed market analysis to optimize equipment selection, forecast demand for collection supplies, and align purchasing strategies with market growth trends in France.
- Healthcare Investors & Consultants : Investment firms and management consultants require France market data to assess investment opportunities, evaluate market attractiveness, and develop business cases for healthcare sector expansion.
- Blood Bank & Transfusion Services : Blood bank directors need market intelligence to plan capital expenditures, evaluate new collection technologies, and understand regulatory trends affecting blood collection operations in France.
Key Companies in the France Blood Collection Devices Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| ATS AUTOMATION TOOLING SYSTEMS INC | Canada | Public Company | Turnkey automation systems (design, build, commissioning),Pre- and post-automation services,Software and digital solutions, |
| ABBOTT LABORATORIES | United States | Public Company | Medical Devices (cardiovascular, diabetes care, neuromodulation),Diagnostic Products (lab, rapid, molecular, point-of-care),Nutritional Products (pediatric, adult, infant formula), |
| NOLATO | Sweden | Public Company | Medical technology components and systems,Pharmaceutical and primary plastic packaging,EMC shielding and thermal management (Compatherm, Compashield, Trishield, MIL SPEC), |
| QIAGEN NV | Netherlands | Public Company | Sample technology consumables and instruments,Immune response (TB IGRA and transplant/viral load assays),Oncology and sexual & reproductive health assays, |
| DANAHER CORPORATION | United States | Public Company | Biotechnology (bioprocessing and related solutions),Life Sciences (research tools and genomic medicine inputs),Diagnostics (clinical instruments and consumables), |
| GRIFOLS, S.A. | Spain | Public Company | Biopharma (plasma-derived medicines),Diagnostic,Bio Supplies, |
| NIPRO CORPORATION | Japan | Public Company | Renal care (hemodialysis machines, dialyzers, blood tubing sets),Injection and infusion devices (syringes, catheters, IV sets),Pharmaceutical packaging (glass vials, ampoules, components), |
| HAEMONETICS CORPORATION | United States | Public Company | Plasma (NexSys PCS, NexLynk DMS, Donor360 and related disposables),Blood Center (whole blood and component collection, software),Hospital Hemostasis & Autotransfusion (TEG 6s, TEG Manager, Cell Saver Elite+), |
| ICU MEDICAL, INC. | United States | Public Company | Infusion therapy & IV solutions,Vascular access & needlefree connectors,Infusion pumps & hardware, |
| CARDINAL HEALTH | United States | Public Company | Branded and Generic Pharmaceutical Distribution,Specialty Pharmaceutical and Manufacturer Services,Medical, Surgical, and Laboratory Products (Cardinal-branded and National Brands), |
| RETRACTABLE TECHNOLOGIES, INC. | United States | Public Company | VanishPoint safety syringes (insulin, tuberculin, allergy antigen),Blood collection sets and tube holders,IV safety catheters and Patient Safe syringes/Luer Caps, |
| AB MEDICAL CO., LTD. | Ireland | Public Company | Cardiovascular Portfolio,Medical Surgical Portfolio,Neuroscience Portfolio, |
ATS AUTOMATION TOOLING SYSTEMS INC
ATS Automation Tooling Systems Inc is a Canadian public company founded in 1978 with 7,000 employees. The company specializes in automation and tooling systems for industrial applications.
ABBOTT LABORATORIES
Abbott Laboratories is a major American public pharmaceutical and healthcare company founded in 1888 with 115,000 employees. The company manufactures and distributes pharmaceuticals, diagnostics, and medical devices globally.
NOLATO
Nolato is a Swedish public company founded in 1938 with 5,607 employees. The company manufactures plastic components and solutions for medical, healthcare, and industrial applications.
QIAGEN NV
QIAGEN NV is a Dutch public company founded in 1984 with 5,500 employees. The company develops and manufactures molecular diagnostics, life sciences, and sample preparation technologies.
DANAHER CORPORATION
Danaher Corporation is a major American public conglomerate founded in 1969 with 59,000 employees. The company operates across multiple sectors including diagnostics, life sciences, and environmental solutions.
GRIFOLS, S.A.
Grifols, S.A. is a Spanish public company founded in 1909 with 25,000 employees. The company develops, manufactures, and distributes plasma-derived medicines and diagnostic solutions.
NIPRO CORPORATION
Nipro Corporation is a Japanese public company founded in 1954. The company manufactures medical devices, pharmaceuticals, and healthcare products.
HAEMONETICS CORPORATION
Haemonetics Corporation is an American public company founded in 1971 with 3,009 employees. The company develops and manufactures blood management and diagnostic solutions.
ICU MEDICAL, INC.
ICU Medical, Inc is an American public company founded in 1984 with 13,000 employees. The company manufactures infusion therapy and critical care medical devices.
CARDINAL HEALTH
Cardinal Health is an American public company founded in 1979 with 55,392 employees. The company is a leading distributor of pharmaceuticals, medical supplies, and healthcare services.
RETRACTABLE TECHNOLOGIES, INC.
Retractable Technologies, Inc is an American public company founded in 1994 with 198 employees. The company manufactures safety-engineered medical devices, including retractable syringes and needles.
AB MEDICAL CO., LTD.
AB Medical Co., Ltd is an Irish public company founded in 1949 with 95,000 employees. The company develops and manufactures medical devices and healthcare solutions.
Reasons to Buy this Report
- Market-Specific Sizing : Obtain precise valuation data for France's blood collection devices market with verified 2025 baseline (USD 426.3M) and 2030 forecast (USD 595.9M), enabling accurate budget allocation and revenue projections.
- Regulatory Landscape Insights : Understand France's unique regulatory environment, EU compliance requirements, and healthcare standards that shape product development, market entry strategies, and competitive positioning in the French market.
- Demographic Opportunity Analysis : Leverage detailed insights into France's aging population trends and their impact on blood testing demand, helping identify high-growth segments and target healthcare facilities with greatest procurement needs.
- Competitive Intelligence : Gain actionable competitive analysis specific to France's market dynamics, including key players, market share distribution, and differentiation opportunities in safety-engineered and automated collection devices.
- Growth Strategy Development : Use France-specific market data and 6.9% CAGR projections to develop targeted expansion strategies, partnership opportunities, and product positioning for hospitals, diagnostic labs, and blood banks across the country.
Frequently asked questions
What is the current size of France's blood collection devices market?
France's blood collection devices market is valued at USD 426.3 million in 2025.
What is the projected market size for blood collection devices in France by 2030?
France's blood collection devices market is projected to reach USD 595.9 million by 2030.
What is the growth rate of France's blood collection devices market?
France's blood collection devices market is growing at a compound annual growth rate (CAGR) of 6.9% from 2025 to 2030.
What factors are driving growth in France's blood collection devices market?
Growth in France is driven by an aging population, increased diagnostic testing volumes, stringent occupational safety regulations, and adoption of safety-engineered collection systems.
Which blood collection device types are most in demand in France?
Safety-engineered devices and automated blood collection systems are experiencing the highest demand in France due to regulatory requirements and clinical efficiency benefits.
RESEARCH METHODOLOGY
This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global blood collection devices market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the growth prospects in the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Secondary Research
This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global blood collection devices market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the growth prospects in the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Primary Research
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative & quantitative information and assess the prospects of the market. Various primary sources from both the supply & demand sides of the market were interviewed to obtain qualitative and quantitative information.
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the blood collection devices market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
Data Triangulation
The total market was split into several segments and subsegments after arriving at the overall market size from the estimation process. Where applicable, data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
Blood collection is the process of acquiring blood samples from patients for diagnostic and therapeutic purposes. It is an integral part of the diagnosis and blood group typing process in hospitals and blood bank centers. The blood collection devices market covers the products used to collect blood from patients/donors.
Stakeholders
- Healthcare Service Providers (Hospitals and Pathology Centers)
- Blood Collection Product Manufacturers
- Blood Banks
- Non-governmental Organizations (NGOs) and Government Organizations Associated with Blood Collection
- Market Research and Consulting Firms
- Venture Capitalists and Investors
Report Objectives
- To define, describe, and segment the global blood collection devices market by product, method, application, end user, and region
- To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
- To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the global blood collection devices market
- To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market players
- To forecast the size of market segments with respect to five major regional segments: North America, Europe, the Asia Pacific (APAC), Latin America, and the Middle East & Africa
- To profile the key players in the market and comprehensively analyze their market positions and core competencies
- To track and analyze competitive developments such as acquisitions, product launches, expansions, agreements, collaborations, and partnerships in the blood collection devices market
Get the Full Blood Collection Devices Market Report
Full forecast, segment splits, and company analysis for all Blood Collection Devices Market.
- Canada Blood Collection Devices Market
- US Blood Collection Devices Market
- Germany Blood Collection Devices Market
- UK Blood Collection Devices Market
- Italy Blood Collection Devices Market
- Spain Blood Collection Devices Market
- Japan Blood Collection Devices Market
- China Blood Collection Devices Market
- India Blood Collection Devices Market
- Australia Blood Collection Devices Market
- Rest Of Europe Blood Collection Devices Market
- Rest Of Asia Pacific Blood Collection Devices Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
